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Abstract 
The introduction of the advanced 
technologies into the medical field entails 
the increase in the average age of the 
population, fact which has as a major 
impact on the increase in the number of the 
medical disorders reported, cases which 
burden the medical system which is 
supposed to ensure medical assistance, at 
least of primary degree, to any particular 
situation. In this work, we bring forward 
the casuistry related to Parkinson’s disease 
both at the level of Romania and at the level 
of the Moldavia region in order to estimate 
the effort which must be made towards 
identifying the model of optimal 
management to be used in order to 
minimize human and material costs when 
approaching this medical disorder. Due to 
the high average age, the issues related to 
Parkinson’s disease become more important 
as the occurrence rate is particularly high, 
around 60-65 years.  
Keywords: epidemiology, Parkinson’s 
disease, parkinsonian syndrome. 
Introduction 
Medicine has evolved from the simple 
procedures of symptomatic treatment to the 
management of the entire medical process 
which includes the treatment of the cause 
of the disease (9).The final diagnosis is not 
anymore just the result of interpreting 
anamnesis and evident clinical signs. The 
diagnosis is the result of a complex 
interdisciplinary activity. When talking 
about Parkinson’s disease we mean 
diagnosis, treatment, results, costs, quality 
of life, etc (2). The management of 
Parkinson’s disease requires that all data 
should be analyzed and considered 
followed by a decision liable to guarantee 
the optimal average for the patient and for 
the medical system of the completion of 
this process. Treatment evolved from 
symptomatic approaches to focusing on 
cause and its removal (5) (13). At the 
beginnings of diagnosing Parkinson’s 
disease, a long time ago, the signs such as 
tremor, muscle stiffness or loosing balance 
were classified as Parkinson’s disease. These 
are evident clinical signs, evident at first 
sight. Nowadays, it has been proved that 
Parkinson’s disease means more than these 
three types of symptoms. In the equation 
are also included cognitive symptoms, 
dementia, depression, etc. (12) and specific 
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management approach must be considered 
(4). The problem evolves from the fact that 
the increasing number of diagnostics 
increases the load on the health public 
system. The epidemiological data has a 
great impact on the managing such already 
public disease.  
Method 
We are interested on the paper on the 
epidemiological impact of this disease. The 
literature was studied, some international 
data are presented. Local data from the 
Direction of Public Health is described as 
well. The aim is to create a good Parkinson 
management model for our geographical 
area. 
As far as the case of Romania is 
concerned, we will present as follows some 
epidemiological data which come from the 
Direction for Public Health. For an average 
population of 21,544,036 persons during 
2005-2009, Figure 1 presents the average 
value according to the age groups in 2005-
2009. 
Considering the demographic 
information mentioned above, we present 
as follows the incidence of Parkinson’s 
disease and of Parkinson’s syndrome, the 
cases being reported by the family 
physicians. 
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Figure 1 The population of Romania according to 
age groups, average values in 2005-2009 
Results 
Figure 2 indicates the incidence of 
Parkinson’s disease at the level of the 
population in Romania during 2005-2009, 
according to age groups. Out of the total 
population represented on the diagram, we 
can notice that most of the cases are 
reported for the age group over 65 years. In 
spite the fact most of the cases reported are 
included in the over 65 years group, this 
medical condition was revealed for the 
range 15-64 as well. 
We can notice that for the age groups 0-1 
years and 1-14 years, there are no cases 
reported. For the age groups 15-64 years 
and 65+, the number of cases which were 
reported increased by almost 75% from 
2005 to 2009. 
Figure 3 presents the number of cases 
suffering from the parkinsonian syndrome 
reported for the period 2005-2009. There 
are less cases than Parkinson’s disease 
reported for the same period and 
undergoing a fall from 2005 to 2009.  
The data we obtained allowed the 
distribution of the reported cases for the 
region of Moldavia, according to counties. 
Figure 4 and Figure 5 present the incidence 
of Parkinson’s disease and of Parkinson’s 
syndrome for the period 2007-2009. The 
distribution is relatively equal for all the 
counties. Only in 2007, the county of 
Suceava reported an almost double 
incidence (per 100,000 inhabitants) in 
comparison with the average value of the 
other counties. 
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Figure 2 Cases of Parkinson’s disease reported 
according to age groups 
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Figure 3 The incidence of the parkinsonian 
syndrome for the period 2005-2009 
(the number of cases) 
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Figure 4 The incidence of Parkinson’s disease 
calculated for the counties of Moldavia for the year  
A 2007, B 2008 şi C 2009 
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Figure 5 The incidence of the parkinsonian syndrome 
calculated for the counties of Moldavia for the year  
A 2007, B 2008 şi C 2009 
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Discussions 
The management of Parkinson’s disease, 
one of the well-known neurodegenerative 
disorders (more than 1 million Americans 
aged over 60 suffer from the disease (1)), 
the second only after Alzheimer, has 
become a true challenge of the present 
times (14). It involves several stages as 
anamnesis, diagnosis, decision over the 
treatment and treatment administration and 
the identification and monitoring of results. 
20% of 1 million persons suffering from 
Parkinson’s disease in the United States of 
America do not present any of the classical 
signs of the disease, such as the resting 
tremor. That is why this aspect has 
determined over the years the false 
diagnosis of Parkinson’s disease. For 
example, the essential tremor has been 
many times confounded with Parkinson-
type tremor. Nevertheless, clinical studies 
(6) showed that the symptom that best 
describes this type of medical disorder is the 
resting tremor, the response asymmetry of 
one part in relation to the other and a good 
response to levodopa. This type of 
differential diagnosis is however not 
absolute. There are several parkinsonian 
symptoms. Primary Parkinsonism or 
Parkinson’s disease is characterized by 
tremor, bradykinesia, stiffness and postural 
instability and from a pathological point of 
view, by losses of pigmented neurons of the 
black substance and eosinophilic 
cytoplasmic inclusions (Lewy bodies). 
Nevertheless, Parkinsonism may be 
produced by injuries of basal ganglia in 
cerebrovascular diseases, infections and 
toxins, also known as secondary 
Parkinsonism.  
As the images shows, the most cases are 
identified on the range of 65+, an 
important number occurs on the range of 
15+64 years old and very few cases bellow 
15 years old. Most of the Romanian 
population is squeezed on the range of 15-
64. If we correlate the numbers, it seems 
that the number of cases is important 
enough comparing the population age and 
ranges. The thing is that the high 
technology and opportunity of treatments 
increase these numbers also and this 
disease, if not yet, will become a problem of 
public health. That’s why, the preventive 
approach impose the early diagnostics of 
such medical condition. It is less costly to 
prevent than to treat. The thing is that the 
Parkinson managements at this moment are 
quite limited for us. Either we do not have 
enough data from the field or not affordable 
procedures are available.  
For the last about 30 years, Levodopa 
was the most used efficient treatment. In 
spite of the very good results on the short 
time basis, the long term can add more 
issues on the patient. The motors 
symptoms could escalate.  
The neurosurgery using brain 
stimulators is an alternative for some 
patients (about 5%). Using invasive 
procedures, certain brain areas are 
stimulated using electrodes. These 
electrodes are connected by cables to a 
controlling and processing box under the 
clavicle. This technique is quite efficient on 
managing the tremors, the rigidity and 
movement Parkinson related disorders. 
There are restrictions though. This 
procedure cannot be proposed to the 
patients suffering of this illness for more 
than 5 years and can be applied only to 
those without neurological complications. 
If the age is not a selection item, the general 
health status must be pretty good.  
Conclusions 
1. Parkinson’s disease is nowadays a 
complex medical disorder which does not 
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involve only problems related to the 
voluntary motor system, but it is also 
associated with non-motor and neuronal 
manifestations. Due to this fact, 
aprroaching the disease over the past years 
evolved from the simple treatment to the 
management of the whole process of 
identification, control and monitoring.  
2. The cost-related problems involved by 
the numerous medical disorders which 
society has to manage, require an approach 
which is superior to the classical allopathic 
approach according to which a disorder had 
a solution which could be solved. The 
diseases became complex or better said, in 
order to understand them better, inter- and 
multidisciplinarity are absolutely necessary. 
Owing to this, the solutions evolved as 
well, from the simple curative drugs to the 
medical procedures for treatment, for the 
systemic approach of the disorders. The 
solutions are in their turn inter- and 
multidisciplinary. The aim of simply 
treating the disease evolved from the simple 
“recovery” to the improvement in the 
quality of life which, most of the time, 
becomes the main objective. The personal 
objective is that related to the quality of life 
while the social objective is that of 
minimizing the social impact of the 
individual on the society and that of the 
society on the individual. The relation is 
mainly a cost-related and efficiency-based 
relation.  
3. The reported epidemiological data 
regarding Parkinson’s disease and the 
parkinsonian syndrome point out a 
considerable incidence which should 
determine us to search for methods and 
models for the management of casuistry 
(8). An important issue is that case 
reporting is very much related to the 
specialist physician who diagnoses a case 
and especially to the preventive education 
of the patient who should see a doctor 
when the symptoms begin to manifest and 
not do this at a great distance in time when 
these symptoms lead to the patient’s 
immobility. Even more so, considering the 
present economic situation due to the 
economic crisis we are passing through and 
whose duration we do not know, the early 
identification with the purpose of carrying 
out procedures for the management of the 
disease at the early stage, would save many 
resources and would relieve the system of 
health insurances as well as the system of 
social security of additional expenses. The 
model primarily used by patients is that of 
seeing the doctor when the medical 
disorders overwhelm them and prevent 
them from carrying out the daily activities. 
Therefore, they get into a situation in 
which they are brought as medical 
urgencies to the hospital where the costs of 
recovery, treatment and monitoring are 
much higher than a process of prevention 
previously peformed would have involved. 
The reported casuistry for our country 
determines us to identify methods for 
raising the patients’ awareness to see the 
doctor in due time in order to maximize the 
therapeutic approach. 
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